Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Franziska Joncourt"'
Autor:
Maja Steinlin, Franz Kaufmann, Roland Kreis, Elisabeth Giger, Peter Vermathen, Karin Zwygart, Chris Boesch, Kevin Wingeier, Franziska Joncourt
Publikováno v:
NMR in Biomedicine. 24:253-262
Duchenne muscular dystrophy (DMD) is a hereditary X-linked recessive disorder affecting the synthesis of dystrophin, a protein essential for structural stability in muscle. Dystrophin also occurs in the central nervous system, particularly in the neo
Autor:
M Fopp, B van Hille, T Cerny, Martin F. Fey, M. Bacchi, Franziska Joncourt, J Reuter, Richard Herrmann, A Lohri
Publikováno v:
European Journal of Haematology. 59:206-215
UNLABELLED Using a modified quantitative reverse transcriptase (RT) PCR assay in 57 patients with acute myeloid leukaemia (AML) from a Swiss Phase III multicentre study (SAKK 30/85), we measured the m-RNA expression of the genes from the multidrug re
Publikováno v:
Clinical Chemistry. 52:2005-2012
Background: Cystic fibrosis (CF) is associated with at least 1 pathogen point sequence variant on each CFTR allele. Some symptomatic patients, however, have only 1 detectable pathogen sequence variant and carry, on the other allele, a large deletion
Autor:
Barbara Neuhaus, Franziska Joncourt, Kristin Jostarndt-Foegen, Stephanie Kleinle, Bernhard Steiner, Sabina Gallati
Publikováno v:
Human Mutation. 23:385-391
Recently developed PCR systems offer online-monitoring of amplification and allow simple and reliable DNA quantification. We have used the LightCycler system to develop a simple and rapid method for direct identification of female carriers of deletio
Publikováno v:
Swiss Medical Forum ‒ Schweizerisches Medizin-Forum. 14
Une patiente d’origine kurde âgee de 49 ans se presente a la consultation pour des myalgies associees a une faiblesse, entrainant des difficultes dans les tâches menageres.
Autor:
Katharina Buser, Thomas Cerny, Aurelia Oberli, H. J. Altermatt, Franziska Joncourt, Marisa Bacchi
Publikováno v:
Gynecologic Oncology. 70:176-182
Drug resistance represents a complex problem for the treatment of ovarian cancer. This study was undertaken to assess several putative resistance parameters (DRP) in parallel in cancer tissue from newly diagnosed patients with ovarian cancer in order
Publikováno v:
Buser, K.; Joncourt, F.; Altermatt, H.J.; Bacchi, M.; Oberli, A.; Cerny, Th. (1997). Breast cancer: Pretreatment drug resistance parameters (GSH-system, ATase, P-glycoprotein) in tumor tissue and their correlation with clinical and prognostic characteristics. Annals of oncology, 8(4), pp. 335-341. Kluwer Academic Publishers 10.1023/A:1008202723066
Summary Background The identification of new factors predicting relapse, outcome and response to systemic therapy in breast cancer is warranted. The measurement of biological markers such as drug resistance parameters (DRPs), which are part of the ph
Autor:
Geoffrey P. Margison, Thomas Cerny, Aurelia Oberli, Franziska Joncourt, Alois Gratwohl, Martin F. Fey, Shelagh Redmond, Andreas Tobler, Kathrin Buser
Publikováno v:
British Journal of Haematology. 85:103-111
Summary. The levels of several potential indicators of resistance to cytostatic drugs were measured in leukaemic cells of a total of 64 adult patients with acute or chronic Ieukaemias before and during treatment and at relapse or recurrence of diseas
Autor:
Roland, Kreis, Kevin, Wingeier, Peter, Vermathen, Elisabeth, Giger, Franziska, Joncourt, Karin, Zwygart, Franz, Kaufmann, Chris, Boesch, Maja, Steinlin
Publikováno v:
NMR in biomedicine. 24(3)
Duchenne muscular dystrophy (DMD) is a hereditary X-linked recessive disorder affecting the synthesis of dystrophin, a protein essential for structural stability in muscle. Dystrophin also occurs in the central nervous system, particularly in the neo
Publikováno v:
Swiss Medical Weekly.